A question & a "Take a look:"
Contax,
Have been lurking for quite some time. I admire what your doing as well as your return to date (your return = the envy of many).
A question (or three): MOBL has been getting beat to death for a while now. Any thoughts from your end as to why? And more particularly, when the bleeding might stop? And most particular of all, are your long term prospects still as rosy (or rosier) as they once were?
I've got a small position and would love to bottom feed and add more on this one.
My "Take a look" - CYGX (Cytogenix)
Chart looks way overbought after a tremendous run-up recently, but 2 great P/R's out this week:
1. Dismissal of a $500M lawsuit (nothing wrong w/that)
2. CytoGenix, Inc. (OTCBB:CYGX - News) and Aldevron, LLC announced positive results of a pilot study using CytoGenix synDNA(TM) as the active ingredient in a Hepatitis B vaccine, demonstrating that it is highly effective in generating an immune response.
Many hurdles left (many many) but some very astute CYGX posters on I-HUB are talking really big things for this little biotech. Might be worth a look. I've got a somewhat larger position in this one.
Good luck and thanks for a job well done. You give us novices some hope in additon to some good leads.
AI
